Treatment of Foot Disease in Patients with Type 2 Diabetes Mellitus using Human Umbilical Cord Blood Mesenchymal Stem Cells: Response and Correction of Immunological Anomalies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|27|4893-4899

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.27, 2013-08, pp. : 4893-4899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential clinical applications using stem cells derived from human umbilical cord blood

By Ghen MJ   Roshan R   Roshan RO   Blyweiss DJ   Corso N   Khalili B   Zenga WT  

Reproductive BioMedicine Online, Vol. 13, Iss. 4, 2006-10 ,pp. : 562-572

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Human umbilical cord blood stem cells, myocardial infarction and stroke

By Copeland Nathan   Harris David   Gaballa Mohamed A  

Clinical Medicine, Vol. 9, Iss. 4, 2009-08 ,pp. : 342-345

Royal College Of Physicians

Access to resources Recommend Favorite

CD271 as a Marker for Mesenchymal Stem Cells in Bone Marrow versus Umbilical Cord Blood

By  

Cells Tissues Organs, Vol. 197, Iss. 6, 2013-05 ,pp. : 496-504

Karger

Access to resources Recommend Favorite

Transplantation of Bone Marrow Mesenchymal Stem Cells for the Treatment of Type 2 Diabetes in a Macaque Model

By  

Cells Tissues Organs, Vol. 198, Iss. 6, 2014-03 ,pp. : 414-427

Karger

Access to resources Recommend Favorite

Ultrastructural and Immunocytochemical Analysis of Multilineage Differentiated Human Dental Pulp- and Umbilical Cord-Derived Mesenchymal Stem Cells

By  

Cells Tissues Organs, Vol. 193, Iss. 6, 2010-12 ,pp. : 366-378

Karger

Access to resources Recommend Favorite